Psychosis and schizophrenia in adults: treatment and management


Key events during the development of the guidance

Date Update
12 February 2014 Guidance published - CG178
2 October 2013 Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received.
20 August 2013 The draft guideline is out for consultation with stakeholders. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.
23 May 2012 Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline. Please see timescales above for dates of consultation with stakeholders.
11 May 2012

A minor change to the wording of the scope has been made (3.3.1)

27 February 2012

The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.

16 February 2012

In line with the draft methods for developing quality standards, the development of the quality standard will be the responsibility of a separate group. This will include topics experts, some of whom will be drawn from the Guideline Development Group. The clinical guideline scope will form the basis from which the clinical guideline will be developed and the quality standard scope will inform the development of the quality standard, which will be developed following completion of the clinical guideline.

16 January 2012

Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply.The National Collaborating Centre and the Institute are in the process of agreeing details of the workplan including how the development will progress, the membership of the Guideline Development Group and timescales.